The central government is set to provide protection to pharmaceutical giant Moderna against legal liability that will make way for immediate import of seven million doses of the company’s Covid-19 vaccine.
The US government has donated these shots and it will be delivered to India upon the resolution of this indemnity issue.
Last week, the Drugs Controller General of India (DCGI) had allowed pharma company Cipla to import these donated doses of the m-RNA vaccine produced by Moderna.
“While India is agreeing to indemnity, we have asked them to suitably modify certain words in the agreement. Wordings make a difference; the analysing and understanding have to be country-specific,” one of the officials from the government was quoted in a report by the Economic Times.
He added, “They need to be refined and that’s what has led to some delay.”
The officer mentioned that the government is anticipating a few million doses of donation from the US government. He further asserted that this quantity would be rather miniscule and hence the country will be relying on its own vaccine production for the inoculation program.
About 33,81,671 people were given their Covid-19 vaccine shots in India on Wednesday, according to a report from the Hindustan Times.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.